Prime portfolios – Performance review and quarterly changes

Prime Portfolios are a set of 19 unique portfolios that meet over 30 different investor needs, aspirations, and timeframes. You will find them under the head Ready-to-use-portfolios (listed in the Recommendations menu, post login). With Prime Portfolios completing close to 2 years, we are now presenting the performance of some of the key portfolios in this article. 

Along with this, you will also find the details of portfolios where we have made changes this quarter. 

Prime portfolios – Performance review and quarterly changes

If you’re new to PrimeInvestor, the first part of this report may be of help as it explains Prime Portfolios. Else, directly go to the section that you’re interested in, in the Table of Contents below.

Construction of Prime Portfolios

We have classified portfolios in Prime Portfolios based on popular financial needs/goals you may have. The basis for many of these would be the goal’s timeframe. We have therefore segregated many of these goals further into timeframe buckets. For those looking for passive investing options, check the Odds and Ends portfolios.

Prime Portfolios largely draw from Prime Funds and mix funds with different strategies to minimize duplication within a portfolio. However, there may be a few cases where funds are outside of Prime Funds too. We use other products, primarily on the fixed income side, in portfolios where they will be good options.

The asset allocation in Prime Portfolios is done based on the ‘ideal’ allocation for a given timeframe, or a given goal. But this is not cast in stone. Assess your own capacity to take risk before choosing a portfolio. These portfolios are not ‘advisory’ in nature. They are bundled MF products with a mix of equity and debt funds and fixed income options with varying strategies for diversification.

Using Prime Portfolios

Prime Portfolios are useful in the following cases:

  1. If you are new to mutual fund investing, or don’t know how to mix funds and want a readymade basket of funds to invest in
  2. If you are an existing investor but have new goals and want an asset-allocated portfolio for that purpose
  3. If you wish to build your own portfolio by taking cues from the asset allocation and category allocation that we use
  4. If you wish to add or modify your existing portfolios by taking cues from Prime Portfolios’ construction using Prime Funds or MF review tool. You can read this article on building your own portfolio.

The following points need to be noted if you follow any of the Ready-to-use portfolios:

  • We internally review these portfolios every quarter after the review of our ratings, recommendations, and Prime Funds. So, this will typically take 2-3 weeks after the end of a quarter.
  • In the review, where we make changes, we will explicitly specify whether a fund needs to be exited or only SIPs should be stopped and investments held. Please take note of the same.
  • If you wish to track changes to a portfolio, please click the ‘Follow’ button to ensure you receive alerts about the changes. Your Dashboard will also show you portfolios that have been changed when you Follow a portfolio.
  • We typically send alerts on changes only for those who ‘Follow’ a portfolio. However, we will also publish a blog on the same every quarter.
  • We will mention only those portfolios where there are actual changes or portfolios to which we wish to draw your attention on any performance dip. Otherwise, you can assume that there are no changes.
  • The changes we suggest may involve fund changes or individual fund allocation changes. Apart from this, some asset classes in your portfolio may have strayed from the original asset allocation as market rallies. This is something only you need to run a check on (as each of you would have invested in different times), once a year, to see whether you need to rebalance. The rebalancing concept is explained in detail in this article on rebalancing, and we have built a calculator to tell you how much to invest/redeem in rebalancing.
  • We will do a review of the portfolio performance since inception at the end of every calendar year. 

Essentially it is important for you to read and record our emails for all of the above. So kindly make sure you find some time to do this to keep your portfolio in good shape!

Performance of Prime Portfolios

With Prime Portfolios set to complete two years, we now have some track record to assess our performance and present them to you. In this review, we present the performance of five most popular portfolios with equity exposure. 

The remaining portfolios fall within the categories of liquid, emergency, income generation, capital preservation or passive. While we have kept a tab of those and can tell you that you are with the right choices, there is little to explain or show by way of ‘beating indices’ in those choices. 

Hence, we have picked only the portfolios below to review our performance and the reason for such performance. Please note the following:

  • The portfolio performance consists of current funds plus funds in which we may have stopped SIPs but asked you to hold (in our earlier quarterly reviews).
  • The performance is weighted based on the proportion of allocation to each fund.
  • The benchmark used is a blended benchmark (with same weights as that of the portfolio) of different indices to represent each of the market-cap or category of funds. For example, a large cap fund would have a large-cap index benchmark, a midcap one a midcap index and so on. 
  • Returns calculated are SIP returns (XIRR) since the inception of these portfolios which is January 1, 2020. Your own returns may vary based on when you entered. The idea here is to provide you with a track record of performance of the portfolios.

The table below summarizes the performance.

3-5-year portfolio performance

This is a portfolio with a 50% allocation each to equity and debt. This is among the portfolios that saw the least changes. We removed Franklin India Corporate Debt from this portfolio, although there was no untoward event in the fund, and stopped SIPs in ICICI Pru Equity & Debt.

This portfolio beat its blended benchmark returns despite the following: one, we took stiff ‘idealistic’ benchmarks in debt, which comprises half the portfolio - ICRA Composite Bond and ICRA AAA Composite Bond. These are indices that funds seldom beat, as they are mostly theoretical benchmarks with no churn and expense ratio, making it unrealistic for debt funds to beat. Nor can you invest in these debt indices, as an alternative to holding the fund.

Two, we compared a passive fund like ICICI Pru Nifty Next 50 with its benchmark index. Expense ratio and a higher tracking error (true of other Next 50 funds as well) resulted in the fund trailing the index. 

Steady performance by Mirae Largecap as well as the bounce back in ICICI Pru Equity and Debt (where we gave a hold on investments already made, but stop on SIPs) helped lift performance. This portfolio suits all those who are conservative want to keep their downside contained even if their time frame is higher than what we have mentioned.

5–7-year portfolio performance

We mince no words here. Our performance in this portfolio is not good! We owe you a proper explanation on this one. We are unhappy with the way we have performed in this portfolio for two reasons, beyond the actual underperformance: one, we made more than a few changes in a span of 2 years, triggered by our own judgement and extraneous factors. Two, no portfolio can afford more than one equity fund underperforming. In this case, we had 2 of them underperforming and one ‘hold’ call underperforming as well. 

Now, the reason for underperformance: The biggest reason is DSP Midcap – a fund that we resonate with quite well as it reflects our philosophy in stocks (if you checked our stock performance review 😊). We built a 5–7-year portfolio laden with equity but one that is designed to contain downsides first. And a bull rally for 1 year and 9 months out of the 2 years of this portfolio’s existence, did not help our noble thoughts 😊

DSP Midcap missed the massive bull rally by staying away from mid and small cap stocks with inferior financial metrics and business fundamentals. A screener of this fund’s portfolio will tell you that it did not compromise on quality or growth metrics on its stock holdings. In other words, we find its portfolio well-constructed with quality stocks. Unfortunately, these simply didn’t rally as much as other ‘rocket’ performers.

Could the fund have taken some tactical calls on commodity stocks or value bets or sectors that moved swiftly? It could have. It did not and stuck to its filters. But what’s redeeming is that it seems to be course-correcting and narrowing the margin of underperformance over shorter periods of 1- and 3-month rolling returns. 

But this is going to be a slow process until such time an overdue correction pulls down this market cap segment, allowing DSP Midcap’s portfolio to work. We are awaiting that. If it takes longer than we think it should, we will rethink our strategy. Meanwhile we introduced the Midcap 150 index fund in April 2021 to ensure your returns are at least in line with the market for a portion of your midcap investment. This was a course-correction we did midway to reduce the pain of waiting for the DSP fund’s performance to bounce back. 

The other fund that slipped but is also now improving is Kotak Multicap. This fund has shown its mettle in the volatile quarter ending December 2021 and is trying to narrow the underperformance margin. We are optimistic but will continue to watch this fund closely and make changes if necessary. 

Another fund in this portfolio, Invesco India Growth opportunities that we gave a ‘stop SIP and hold’ call in April 2021 continues to underperform. What we’re planning is to wait for a year since we moved this fund’s call to a Hold, so that tax benefits are not lost. Once this period is done, we will undertake a complete clean-up of this portfolio with exit calls on funds that are poor performers and make this portfolio more agile. If you had invested post March 2021, your portfolio underperformance would be less as you would not have exposure to this Invesco fund. 

We replaced the above Invesco fund with Invesco India Contra, and we see no concerns there right now although the bull rally may not bring the best in this fund either. The debt funds in this portfolio held up well, performing as much as they could in this low-rate scenario. We have no qualms there.

Greater than 7-year portfolio performance

The earlier portfolio may almost seem to suggest that we punished you for holding for a lesser time frame! 😊 The greater than 7-year portfolio has done quite well, even without any high-risk funds, thanks to the top-performing Parag Parikh Flexicap with its international exposure.  

Even the gilt fund there has beaten its benchmark comfortably. So, the learning – some diversification to a different market made a difference. Why did we not have such diversification in the 5–7-year portfolio as well? Unfortunately, our data tells us that international investing can also go way wrong in a different market phase, have prolonged sideways phases and can pull down returns (it did in the last 2 quarters of 2021, actually). We therefore wanted only our long-term portfolios to be exposed to international stocks. Perhaps this notion needs a revisit with newer and less volatile international passive options coming up!

Coming back, the only fund that needs a rehaul in the greater than 7-year portfolio is the Invesco India Growth Opportunities fund that we gave a ‘stop SIP and hold’ call in April 2021. As is the case with the 5–7-year portfolio, we will do a clean-up at the end of March 2022, to provide some tax advantage on exit.

High-growth portfolio performance

Against the 7+ year portfolio, the High Growth portfolio may actually come as a disappointment. This is the second portfolio where we are unhappy with performance. 

This portfolio’s underperformance against the blended benchmark is not steep like it is with the 5-7 year portfolio - it is mostly due to three factors: one, the Nifty Next 50 index fund (these funds typically have higher tracking error). Two, the debt component (where beating index is hard, for reasons explained earlier, above). Third, the slight lag in Invesco India Contra, which we are not concerned about as it is turning around. None of these are matters of concern to us.

Our disappointment primarily comes from the returns itself, as we built this portfolio to deliver high growth which it has not lived up to. This is because, the high-growth component of this portfolio comes from a heavy weight of 45% to small-cap funds and the Nifty Next 50 index. This is where the portfolio has not delivered.

First, take the small-cap space. We started out with HDFC Small-cap but replaced it with SBI Smallcap early in 2020 as the HDFC fund’s performance started to dip. With investment restrictions unfortunately introduced in the SBI fund, we changed it to Axis Small Cap in late 2020. 

HDFC Small-cap beats the Smallcap 100 index, but is not a chart-topper. SBI Smallcap has been an underperformer, undershooting the Smallcap index by a wide margin for much of the small-cap rally over the past two years – at one point, the fund’s gap with the index was over 20 percentage points. Like in the mid-cap space, the nature of the upswing saw funds that were more fundamentally-driven take a backseat in performance. The fund is turning around now, narrowing the underperformance against the index.

Besides dragging overall portfolio returns, SBI Smallcap’s underperformance also contributes to the gap with the blended benchmark index. Finally, the current small-cap fund – Axis Smallcap – did not set the category on fire, either. While it beat the index well, its actual returns have been far below peers in this rally.  

Second, take the Nifty Next 50. The Next 50 also did not return as much as we expected it to; the index, based on trends in earlier market cycles, typically soared during market rallies. Returns did not turn out quite that way, thanks to the heavy weights of financial services, consumption, and pharma in the index – segments that took a backseat in this rally.

We’re still positive on both the Next 50 and Axis Smallcap. A key factor that’s in Axis Smallcap’s favour is its ability to keep losses well in check in times of market correction, at which it is among the best in its category. With this portfolio already an aggressive one, keeping downsides contained is especially important to retain the gains made during upswings.

Given that we’re in an over-heated market territory, we’re wary of switching into more aggressive funds at this time, in the small-cap space. We see that funds that have been taking short-term calls in small-cap stocks are the ones topping the charts and we are clear we would not take exposure to such funds as the strategy cannot sustain for long. 

We can only be on a wait and watch mode with small caps at this time. 

The other calls in the portfolio made up for part of the slack in the small-cap segment. The Nasdaq 100, for instance, served up a good booster.

Active NRI portfolio performance

This portfolio has delivered well, beating the blended benchmark index. This performance is thanks in part to Parag Parikh Flexicap’s stellar returns. The steady returns of Mirae Asset Largecap also helped deliver index-beating returns. These two funds make up more than a third of the portfolio weight. The only portfolio drag is Invesco Growth Opportunities, which is still lagging the index. Like with other portfolios that hold this fund, we will clean this up post March 2022.

Changes made in this quarter

In this quarter, we have made changes only to one portfolio – the Emergency portfolio. All other portfolios see no changes at all.

Emergency portfolio

This portfolio is made up of liquid funds and money market funds. It is mainly for you to hold your investments set aside to meet emergencies or any other short-term need. 

In this review, we have replaced Kotak Money Market with Nippon India Money Market. The replacement is simply because the Nippon fund has been sporting better portfolio yields for a few quarters now and to this extent can offer better returns.

If you hold Kotak Money Market, continue to hold it. Do not exit. The fund remains a good performer within the money market category, it is just not a chart-topper. It takes no credit risk and sees very low volatility. The aim in an emergency portfolio is to hold stable, safe investments. It is not to keep churning to eke out marginally higher gains or beat peers/benchmark. If you have SIPs in the fund, you may choose to stop and start in the Nippon fund but we do not think doing so is necessary. 

The changes are summarised below.

Key notes in the 3-5 year and 5-7 year portfolios

Both these portfolios have Axis Banking & PSU Debt funds. This fund was part of our Prime Funds list, in the Debt - Short-term 1.5 to 3 year bucket. We removed the fund from Prime Funds in this review, for the following reason – it followed a roll-down strategy, where it gradually reduces its portfolio maturity. This brought the fund’s average maturity to less than 1 year. For this reason, we did not think it fit investors entering this fund afresh for 2 year and longer goals. We also need to watch the tenure to which the fund rolls back (increases maturity) once it completes its current rolldown strategy. 

In a portfolio, though, it is a different matter. In both our portfolios, the Axis fund is blended with HDFC Corporate Bond fund. The aim in using both funds was to have a mix of short-term and medium-term maturities so that different opportunities were captured, no matter what the rate cycle was. This logic continues to hold. Axis Banking & PSU is now a very short-term play, from the approximately 2-3 year play it was earlier. This still blends well with HDFC Corporate Bond’s 4-4.5 year maturity. 

We see no reason at this time to replace Axis Banking & PSU with any other short-term fund. The fund is also a buy in our MF Review Tool. We’ll keep an eye on how the maturity changes once the roll-down strategy completes and then take a decision on whether to make any changes. As of now, we are not changing the two portfolios. Continue SIPs and/or fresh investments.

More like this

7 thoughts on “Prime portfolios – Performance review and quarterly changes”

  1. Thanks for the review. I have been investing in the High Growth portfolio for 10 months now and the returns are at ~3.3%. Is that expected?

    1. I am not sure when you saw such return and how you invested. The SIP return (for the portfolio with weights) for that period would have been about 22% and lumpsum also likely higher than what you mentioned. So something not ok with the returns you mentioned. Vidya

  2. While reading the article, I didn’t know the breakdown of the individual portfolios. Suggestion: Perhaps each of the portfolio components can be included in the article, for easy reading + understanding. Thanks.

  3. I had queries on the axis banking and psu fund which have been satisfactorily answered here – thanks

  4. HI,
    The following things are not clear. Request you to explain , Click the “Follow up Button”. But where ?
    Second, Rebalancing of Portfolio : May be you could explain with examples
    A suggestion: why not introduce the concept of model Portfolio, Aggressive
    , Moderate, Conservative.
    It may be easier to follow Model Portfolio.
    Bala

    1. The Follow button is on the portfolio page, not here in the blog. Go to the portfolio you’re interested in and the button will be on the top-right corner. Rebalancing is covered in the article linked in the post – here: https://www.primeinvestor.in/how-to-rebalance-your-portfolio/. You can use our calculator here: https://www.primeinvestor.in/calculators/rebalancing-calculator/. Just input the current values of the equity and debt portion in your portfolio, and the original allocation. The need for rebalancing will be very individual, based on when you started investing and how much. – thanks, Bhavana

Comments are closed.

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

Have an account?
Login To Your Account
OR
Don’t have an account ? Register for free